Search NEL Online

Comparative Study 2010; 31(5): 673-678 PubMed PMID: 21173741 Citation  Keywords:  Aged, Biomarkers:blood, Body Mass Index, Cholesterol, HDL:blood, Cholesterol, LDL:blood, Comorbidity, Diabetes Mellitus:blood, Female, Humans, Male, Middle Aged, Obesity:blood, Poland:epidemiology, Regression Analysis, Resistin:blood, Triglycerides:blood,.   

OBJECTIVES: Plasma cholesterol, triglycerides and serum resisistin may all be influenced by diabetes and obesity, but their associations remain unclear. Therefore, we put forward a hypothesis that serum lipids might be parallel to resistin, as they all reflect the metabolic status of obese humans.

DESIGN AND SETTING: We measured the concentrations of resistin, total cholesterol (TC), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C) and triglycerides (TG) in 134 obese non-diabetic (73 women and 61 men) and 65 obese diabetic (33 women, 32 men) humans, and examined their interrelations. Obesity was defined according to the WHO criterion (BMI, ≥ 30 kg/m²) The presence of diabetes was the only differentiating factor between two groups of frankly obese humans.

RESULTS: Non-diabetic vs. diabetic, median and interquartile range, respectively: resistin (ng/mL) 26.08, 16.09 vs. 22.37, 14.54, p=0.736; TC (mmol/L) 5.02, 1.39 vs. 5.16, 1.56, p=0.374; HDL-C (mmol/L): 1.10, 0.41 vs. 1.02, 0.47 p<0.05; LDL-C (mmol/L): 3.00, 1.05 vs. 3.00, 1.30 p=0.978; TG (mmol/L) 1.70, 1.43 vs.1.95, 1.81 p<0.05. To investigate the interrelations between resistin and lipids, a simple regression analysis was used, and the results were for resistin & TC, HDL-C, LDL-C, and TG, respectively: in the whole cohort r=-0.1364, p=0.0670, r=0.1514, p=0.0437, r=-0.2573, p=0.0006, r=0.0434, p=0.5597; in non-diabetics: r=-0.2067, p=0.0213, r=0.1023, p=0.2621, r=-0.2399, p=0.0083 and r=0.0288, p=0.7497; in diabetics r=0.0280, p=0.8360, r=0.2267, p=0.0929, r=-0.2933, p=0.0298, r=0.1349, p=0.3127.

CONCLUSIONS: In diabetic and non-diabetic subjects the atherogenic LDL cholesterol shows an inverse correlation with resistin, whereas the protective anti-atherosclerotic HDL cholesterol is positively correlated with resistin....

Read abstract  Full text PDF

Journal Article 2010; 31(4): 559-567 PubMed PMID: 20802451 Citation  Keywords:  Adipose Tissue:metabolism, Adolescent, Diabetes Mellitus, Type 1:metabolism, Female, Glucose:metabolism, Glycerol:metabolism, Humans, Lactic Acid:metabolism, Male, Microdialysis, Statistics, Nonparametric, Young Adult,.   

OBJECTIVE: The study was undertaken to assess the interstitial, adipose tissue concentrations of glucose, lactate and glycerol in teenagers with diabetes type 1 who suffered from the disease for a minimum of 5 years, in whom it was impossible to reach a satisfactory level of metabolic control of the disease.

METHODS: Using microdialysis technique interstitial concentrations of glucose lactate and glycerol was measured in adipose tissue during 24-48 hours. Nineteen teenagers with poorly controlled type 1 diabetes (HbA1c 8.9±2.85%) were compared with six adolescent control subjects.

RESULTS: A statistically significant differences in concentration values of interstitial glucose between the investigated and control groups were found (10.4 vs. 4.26 mmol/l p=0.001). The values of interstitial concentrations of lactates did not significantly differ in the two groups (2.96 vs. 2.54 mmol/l NS). The average daily glycerol concentrations in the investigated group were statistically significantly lower than those in the control group (258.26 vs. 397.88 µmol/l, p=0.019). No such difference was detected in average night concentrations of glycerol (157.78 vs. 361.4 µmol/l, NS).

CONCLUSIONS: Authors conclude that microdialysis is the only one minimal invasive method for investigating adipose tissue metabolism in vivo and provides a novel opportunity for glucose and lipids metabolism monitoring in adolescents with diabetes type 1. In our observations interstitial glycerol concentrations, measured in abdominal subcutaneous adipose tissue as an index of lipolysis, were not significantly influenced by hyperglycemia in diabetic adolescents....

Read abstract  Full text PDF

Journal Article 2010; 31(3): 399-405 PubMed PMID: 20588250 Citation  Keywords:  Adult, Cognition Disorders:complications, Depression:complications, Diabetes Mellitus, Type 2:complications, Female, Hemoglobin A, Glycosylated:metabolism, Humans, Male, Middle Aged, Psychomotor Performance,.   

OBJECTIVES: The most important factors in the pathogenesis of cognitive disorders in diabetes mellitus (DM) are metabolic changes directly caused by hyperglycemia. Impairment of cognitive function is accompanied by a decrease in cerebral insulin. Insulin improves cognitive processes, including somatosensoric cognitive functions. Cognitive disorders are especially pronounced if diabetic patients suffer also from depression.

MATERIAL AND METHODS: The evaluation of cognitive functions, especially sensomotoric skills were obtained from three study groups (aged 37-52 years): 30 healthy subjects, 40 diabetic patients with clinically documented depression and 30 depressive patients without DM. The sensomotoric skills were carried out using a SPS-2001E apparatus - a computer working stress simulator. The examination with Beck Depression Inventory (BDI) were also performed in all the investigated persons.

RESULTS: Sensomotoric skills investigation revealed slight cognitive disorders in the early stages DM (subgroup IA) and its intensification according to increasing BDI scores and HbA1c blood concentration (from subgroup IA to IC). Intensification of sensomotoric cognitive disorders was significantly higher (p<0.001) in the depressive patients with DM (group I), than in these without DM (group III).

CONCLUSIONS: The obtained results suggest that coincidence of aggravating factors, such as depression and metabolic disorders in DM, may cause mutual interactions leading to premature and more intense cognitive impairment. The method proposed by the authors may serve as a screening examination in early diagnosis of CNS disorders reflected by somatosensoric cognitive disorders. The presented work indicates importance of sensomotoric skills investigation for the early diagnosis of the nervous system damage related to DM....

Read abstract  Full text PDF

Journal Article 2010; 31(3): 313-318 PubMed PMID: 20588243 Citation  Keywords:  Animals, Antioxidants:pharmacology, Blood Glucose:drug effects, Body Weight:drug effects, Carbolines:pharmacology, Diabetes Mellitus, Experimental:drug therapy, Glycosylation End Products, Advanced:metabolism, Kidney:drug effects, Male, Oxidative Stress:d.   

OBJECTIVES: Recent basic research and clinical data have provided new insights into the role of glycoxidative and nitrosative stresses (both oxidative stress) in diabetic complications, such as diabetic nephropathy, suggesting a different and innovative approach to antioxidant therapy. In streptozotocin-induced diabetic rat kidney, the present study investigated the effects of the synthetic pyridoindole antioxidant stobadine (STB) on renal total antioxidant potential (AOP) and protein oxidation parameters such as protein carbonyl content (PCC), advanced oxidation protein products (AOPPs) and nitrotyrosine (NT), a marker specific for protein modification by peroxynitrite.

MATERIALS AND METHODS: Wistar Albino rats were divided into two groups: normal and streptozotocin-induced diabetic rats. Each group of the animals was further divided into two groups: untreated and treated with stobadine (24.7 mg/kg) during 16 weeks daily by oral gavage.

RESULTS: The renal tissue AOP and the levels of AOPPs, PCC and NT were increased in diabetic rats compared with the untreated control animals. Furthermore, stobadine treatment significantly decreased protein carbonylation and AOPPs but not NT.

CONCLUSIONS: These findings indicate that STB is an antioxidant factor which can improve glycoxidative stress markers in kidney, while it has no effect on protein nitrosylation....

Read abstract  Full text PDF

Journal Article 2010; 31(2): 261-264 PubMed PMID: 20424576 Citation  Keywords:  Adult, Aged, Catalase:blood, Diabetes Mellitus, Type 2:blood, Diabetic Neuropathies:blood, Endothelin-1:blood, Endothelium:physiopathology, Female, Glutathione:blood, Humans, Male, Middle Aged, Neuralgia:blood, Nitric Oxide:blood, Oxidative Stress, Survey.   

OBJECTIVE: The roles of endothelin-1 (ET-1) and oxidative stress causing vascular injury in the pathogenesis of diabetic neuropathy are debatable. The present study was undertaken to clarify the possible effects of oxidative stress and ET-1 in diabetic patients with and without peripheric neuropathy.

METHODS: We studied plasma ET-1, nitric oxide (NO), catalase, glutathione (GSH) levels of fifty (22 females, 28 males) patients with Type 2 diabetes in order to evaluate endothelial dysfunction and oxidative stress. The neuropathy types (motor, sensorial and sensorimotor), comorbid diseases, antidiabetic treatments, smoking, diabetes duration were also considered. Short McGill Pain Questionnaire (SF-MPQ) was also performed for patients with neuropathy.

RESULTS: There were no significant differences between patients with (n=23) and without (n=27) neuropathy with regards to demographic features except diabetic disease duration. The statistical analysis was done considering this difference. Although NO and ET-1 levels were higher, and catalase and GSH levels were decreased in neuropathic patients, no statistical significancy was found. We also couldn't find any correlations between the parameters and SF-MPQ scores.

CONCLUSIONS: Although there were no relationships between neuropathy and the studied parameters, we found lower levels of catalase and GSH as intracelluler antioxidants and higher NO and ET-1 as markers of endothelial injury in patients with neuropathy. Our data suggest that there is a need of further studies with larger study groups in order to clear out the role of endothelial injury and oxidative status in the pathogenesis of diabetic neuropathy....

Read abstract  Full text PDF

Journal Article 2009; 30(1): 144-152 PubMed PMID: 19300402 Citation  Keywords:  Animals, Bradykinin:administration & dosage, Bradykinin Receptor Antagonists, Diabetes Mellitus, Experimental:chemically induced, Diabetic Neuropathies:chemically induced, Drug Evaluation, Preclinical, Enzyme Inhibitors:administration & dosage, Hyperalges.   

PURPOSE: The influence of an irreversible inhibitor of constitutive NO synthase (L-NOArg; 1.0 mg/kg ip), a relatively selective inhibitor of inducible NO synthase (L-NIL; 1.0 mg/kg ip) and a relatively specific inhibitor of neuronal NO synthase (7-NI; 0.1 mg/kg ip), on antihyperalgesic action of selective antagonists of B2 and B1 receptors: D-Arg-[Hyp3,Thi5,D-Tic7,Oic8] bradykinin (HOE 140; 70 nmol/kg ip) or des Arg10 HOE 140 (70 nmol/kg ip) respectively, in model of diabetic (streptozotocin-induced) and toxic (vincristine-induced) neuropathy was investigated.

METHODS: The changes in pain thresholds were determined using mechanical stimuli--the modification of the classic paw withdrawal test described by Randall-Selitto.

RESULTS: The results of this paper confirm that inhibition of bradykinin receptors and inducible NO synthase but not neuronal NO synthase activity reduces diabetic hyperalgesia. Pretreatment with L-NOArg and L-NIL but not 7-NI, significantly increases antihyperalgesic activity both HOE 140 and des Arg10 HOE 140. It was also shown that both products of inducible NO synthase and neuronal NO synthase activation as well as bradykinin are involved in hyperalgesia produced by vincristine. Moreover, L-NOArg and 7-NI but not L-NIL intensify antihyperalgesic activity of HOE 140 or des-Arg10HOE 140 in toxic neuropathy.

CONCLUSIONS: Results of these studies suggest that B1 and B2 receptors are engaged in transmission of nociceptive stimuli in both diabetic and toxic neuropathy. In streptozotocin-induced hyperalgesia, inducible NO synthase participates in pronociceptive activity of bradykinin, whereas in vincristine-induced hyperalgesia bradykinin seemed to activate neuronal NO synthase pathway. Therefore, concomitant administration of small doses of bradykinin receptor antagonists and NO synthase inhibitors can be effective in alleviation of neuropathic pain, even in hospital care....

Read abstract  Full text PDF

Journal Article 2009; 30(1): 119-124 PubMed PMID: 19300390 Citation  Keywords:  Adult, Brain Mapping, Case-Control Studies, Cerebrum:pathology, Depression:complications, Diabetes Mellitus:pathology, Diabetic Neuropathies:complications, Dominance, Cerebral:physiology, Evoked Potentials, Visual, Female, Humans, Male, Middle Aged, Psych.   

OBJECTIVES: The present study was undertaken in order to verify the hypothesis stating that patients with depression exhibit some abnormalities concerning a cerebral symmetry. For this purpose, an analysis of the relationship between the VEPs (Visual Evoked Potentials) results and the depressive symptoms intensification, as well interrelation between depressive and diabetic symptoms were performed.

MATERIAL AND METHODS: VEPs recordings were obtained from the two study groups (both aged 20-45 years), 20 healthy subjects and 32 diabetic patients with clinically documented depression. The VEPs examination was carried out using a computer system called STELLA (Stimulated Electroencephalogram on Line Analyzer).

RESULTS: VEPs examinations revealed a cerebral symmetry in the all control subjects and in 10 out of 32 diabetic patients with depressive disorders. It is noteworthy that 22 of 32 diabetic patients (68.8%) showed a hemispheric asymmetry in the VEPs recordings. Of 12 patients with a moderate depression, 10 showed the left cerebral laterality, and 2--the right laterality. In turn, all 10 patients with major depressive disorder (MDD) demonstrated in the VEPs recordings a significant cerebral laterality with the right hemisphere dominance.

CONCLUSIONS: The obtained results suggest that interhemispheric cerebral asymmetry might be considered a specific feature of depression, and, if this is a case, it could justify a conclusion that right hemisphere dominance could be a neurophysiological marker of MDD. It should be emphasized that intensification of the depressive symptoms has an unfavorable influence on course of diabetes mellitus, its self-control and severity of following complications....

Read abstract  Full text PDF

Case Reports 2009; 30(1): 22-24 PubMed PMID: 19300386 Citation  Keywords:  Adult, Diabetes Mellitus, Type 2:complications, Exercise Therapy:methods, Humans, Male, Motor Activity:physiology, Obesity:complications, Time Factors, Treatment Outcome,.   

: The case history of a 44-year-old, severely obese Caucasian man with serious decompensation of diabetes and subsequent withdrawal of high-dose insulin is reported. Insulin was withdrawn after 5 years of continuous therapy and the patient was treated for 6 months with diet, individualized physical therapy and oral antidiabetic drugs from the group of insulin sensitizers. Six months later, oral antidiabetics were discontinued for low blood glucose levels, and the treatment was limited to therapeutic life style changes. After insulin withdrawal, the patient's condition markedly improved: he showed better diabetes control, decrease in insulin resistance, weight loss, reduced BMI, reduced waist circumference, sagittal abdominal diameter and body fat, increased fitness level, normalized blood pressure and decreased heart rate at rest....

Read abstract  Full text PDF